| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
14,375 |
8,888 |
$9.33M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
29,740 |
19,081 |
$1.41M |
| 92134 |
|
43,211 |
28,770 |
$1.04M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,361 |
5,811 |
$335K |
| J9035 |
Injection, bevacizumab, 10 mg |
4,036 |
2,924 |
$267K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,431 |
3,910 |
$167K |
| 92250 |
|
3,690 |
2,752 |
$167K |
| 92235 |
|
2,583 |
1,983 |
$162K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,254 |
2,571 |
$161K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,788 |
2,673 |
$155K |
| 67228 |
|
767 |
546 |
$135K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,047 |
822 |
$82K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
102 |
66 |
$72K |
| 67210 |
|
173 |
137 |
$53K |
| J0177 |
Injection, aflibercept hd, 1 mg |
15 |
13 |
$51K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
362 |
323 |
$32K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
247 |
191 |
$12K |
| J3590 |
Unclassified biologics |
181 |
102 |
$2K |
| 99024 |
|
722 |
508 |
$0.00 |